In response to the majority deal information on the Nationwide Inventory Change (NSE), Docon Applied sciences offloaded a little bit over 53.32 lakh shares, or 10.06 per cent stake, within the firm.
The transaction was valued at round Rs 667.69 crore, and was executed at a mean value of Rs 1,252.03 apiece.
After the stake sale, Docon Applied sciences’ holding in Thyrocare Applied sciences has come all the way down to 61 per cent from 71.06 per cent.
In the meantime, ICICI Prudential Mutual Fund (MF), Aditya Birla Solar Life MF, HDFC MF, HSBC MF, Eastspring Investments collectively bought 42.11 lakh shares, or 7.95 per cent stake, at a mean value of Rs 1,252 per share.
Eastspring Investments is an arm of British multinational Prudential.This took the deal worth to Rs 527.23 crore.Particulars of the opposite patrons of Thyrocare Applied sciences shares couldn’t be ascertained on the NSE.
In a regulatory submitting, Thyrocare Applied sciences on Friday stated Docon Applied sciences Pvt Ltd, a promoter of the corporate, has bought 53,32,860 fairness shares of the corporate via market trades for an mixture gross consideration of Rs 667.69 crore.
The corporate bought about 10 per cent of the overall paid-up capital.
“Following this transaction, Docon continues to be a promoter of the corporate. Put up this transaction, the promoter shareholding within the firm stands diminished to 60.93 per cent from the pre-transaction shareholding of 70.98 per cent,” Thyrocare Applied sciences stated.
Shares of Thyrocare Applied sciences rose 1.99 per cent to shut at Rs 1,269.70 apiece on the NSE.
